Platelet activation and its role in thrombin generation in platelet-induced thrombin generation time

Thrombosis Research

Volumn 100, Issue 5, 2000, Pages 419-426

  Radziwon, P ^a   Boczkowska Radziwon, B ^a   Schenk, J F ^a   Wojtukiewicz, M Z ^a   Kloczko, J ^a   Giedrojc J ^a   Breddin, H K ^a  

^a Regional Center for Transfusion Medicine   (Poland)

Author keywords

F1+2; PF4; PITT; Platelets; Thrombin generation; TG

Indexed keywords

BETA THROMBOGLOBULIN; PROTHROMBIN; THROMBIN; THROMBOCYTE FACTOR 4;

ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PHOTOMETER; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ADULT; HUMANS; MALE; PLATELET ACTIVATION; THROMBIN; THROMBIN TIME;

EID: 0034527264     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00347-9     Document Type: Article

References (22)

1. Effects of hirudin and two synthetic thrombin inhibitors on platelet function in the presence and absence of citrate
2. 2 on anti-Xa activity of heparin and its molecular weight fractions
3. Ratios of anti-factor Xa to anti-thrombin activities in recalcified human plasma
4. Platelet-induced thrombin generation time (PITT) - A new sensitive global assay for platelet function and coagulation. Method and first results
5. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor
6. Hemocompatibility of treated polystyrene substrates: Contact activation, platelet adhesion, and procoagulant activity of adherent platelets
7. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: Evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses
8. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion
9. A recombinant hirudin (IK-HIR02) in healthy volunteers: II. Effects on platelet adhesion and platelet induced thrombin generation time
10. Laboratory monitoring of new antithrombotic drugs
11. Platelet-induced thrombin generation time II (PITT II): A modified global coagulation test to monitor prophylactic anticoagulation with vitamin K antagonists?
12. Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNa (S-2238)
13. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide
14. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation
15. Formation and regulation of platelet and fibrin hemostatic plug
16. Platelet procoagulant activity: Physiological significance and mechanisms of exposure
17. Platelet plasma membrane glycoproteins
18. Von Willebrand factor and von Willebrand disease
19. Ca2+-dependent protease in human platelets. Specific cleavage of platelet polypeptides in the presence of added Ca2+
20. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin
21. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo
22. Platelet procoagulant activity is independent of aggregation